Home
About
Overview
Sharing Data
ORCID
Help
History (7)
On Patient Safety: Have The ACGME Resident Work Hour Reforms Improved Patient Safety?
Osteosarcoma development and stem cell differentiation.
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.
Hematopoietic stem cell transplantation for myelofibrosis.
Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation.
Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010 Nov; 25(11):2447-59.
View in:
PubMed
subject areas
Alkaline Phosphatase
Animals
Biomarkers
Bone Matrix
Calcification, Physiologic
Cell Differentiation
Cell Line
Cell Proliferation
Chondrocytes
Fetus
Growth Differentiation Factor 2
Humans
Hypertrophy
Implants, Experimental
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor Binding Protein 4
Insulin-Like Growth Factor II
Mesenchymal Stem Cell Transplantation
Mice
Osteogenesis
Phosphatidylinositol 3-Kinases
Proto-Oncogene Proteins c-akt
Signal Transduction
Smad Proteins
authors with profiles
Russell Reid
Rex Haydon
Hue Luu
Tong-Chuan He